Clinical Trial Update: T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

View source ↗

Summary

This clinical trial update describes evaluating T-cell minimal residual disease (MRD) in acute lymphoblastic leukemia using flow cytometric analysis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: Stanford University | Conditions: Leukemia, Lymphocytic, Acute | Status: COMPLETED